Barbara Apgar, MD, MS

    Barbara S. Apgar, MD, MS is a Professor of Family Medicine at the University of Michigan Medical Center in Ann Arbor, Michigan.  She was the Service Chief of the Family Medicine Obstetrical Service for over 20 years.  She performs colposcopy and outpatient gynecologic procedures and has special interests in menopause, HPV, DES, and diseases of the vulva. She is the co-author of a textbook and atlas of colposcopy and a colposcopic image library on CD.


    Kevin Ault, MD

    Kevin Ault, MD is a Professor of Obstetrics and Gynecology and Division Director at the University of Kansas Medical Center in Kansas City, KS, USA. Dr. Ault received his undergraduate degree from Butler University and his medical degree from Indiana University, both in Indianapolis, IN, USA.  Dr. Ault did his residency in obstetrics and gynecology at Ohio State University in Columbus, OH, USA. Dr. Ault's research and clinical interests are infectious diseases and women's health. He has been an investigator in a wide variety of translational and clinical research involving vaginitis, gonorrhea, Chlamydia, herpes and human papillomavirus. Dr. Ault is a fellow of the American College of Obstetricians and Gynecologists and a fellow of the Infectious Society of America.




    Vicki Benard, PhD

    Vicki Benard, PhD, is an epidemiologist with more than 20 years’ experience working in the Center for Disease Control and Prevention’s Division of Cancer Prevention and Control. Her current role is the Chief of the Cancer Surveillance Branch which supports the National Program of Cancer Registries capturing cancer incidence data on over 97% of the US population. Dr. Benard did her undergraduate work in statistics at the University of South Alabama, and earned her doctorate in biometry and epidemiology from the Medical University of South Carolina. Much of her research has examined cervical cancer control in the CDC’s National Breast and Cervical Cancer Early Detection Program.




    J. Michael Berry-Lawhorn, MD

    Dr. Berry-Lawhorn is a Clinical Professor of Medicine at the University of California San Francisco (UCSF). He has worked with Joel Palefsky and Naomi Jay since 1993 in what is now the Anal Neoplasia Clinic, Research, and Education Center and is the Associate Director of HPV-related Clinical Studies. The group has pioneered the use of high-resolution anoscopy (HRA) in not only diagnosing and treating precancerous lesions of the anus, but also in the early diagnosis of anal cancer including, superficially invasive squamous cell carcinoma (SISCCA).  He is an active member of the HPV Working Group of the AIDS Malignancy Consortium and the ANCHOR Anal Cancer Prevention Study Protocol Co-Chair.




    Marci Bowers, MD

    Marci Bowers, MD of Burlingame, California is a pelvic and gynecologic surgeon with more than 26 years’ experience in women’s healthcare. She is a University of Minnesota Medical School graduate and former class and student body president. Her Ob/Gyn residency was at the University of Washington. She remained in Seattle as an Obstetrician/Gynecologist at the Polyclinic and Swedish Medical Center, having delivered more than 2000 babies over 20 years. She added to her  reconstructive pelvic surgery experience during her tenure in Trinidad, Colorado from 2003-2008. Asked by the organization, Clitoraid, Dr. Bowers apprenticed with noted French surgeon, Pierre Foldes in 2007-2009 to learn the technique of functional clitoral restoration after FGM, becoming the first US surgeon to do so. Dr. Bowers relocated her surgical practice to the San Francisco Bay Area in 2010. Dr. Bowers also holds an active faculty appointment at Mt. Sinai-Beth Israel in New York.



    Philip Castle, PhD, MPH

    Dr. Philip Castle is a Professor in the Department of Epidemiology and Population Health at Albert Einstein College of Medicine, Bronx, N.Y., USA. He was a Senior, Tenured Investigator (2010-11) and Tenure-Track Investigator (2003-10) in the Division of Cancer Epidemiology and Genetics (DCEG) at the U.S. National Cancer Institute (NCI). Dr. Castle received his Ph.D. in Biophysics in 1995 and M.P.H. in Epidemiology in 2000 from the Johns Hopkins University. For his work in cervical cancer prevention, Dr. Castle has received (1) an EUROGIN Distinguished Service Award (2006); (2) a NIH Merit Award for introduction of HPV testing into low-resource settings in the U.S. (2007); (3) a Distinguished Scientific Achievement Award from the ASCCP (2010); (4) The Arthur S. Flemming Award for Exceptional Achievement in Federal Government Service for Applied Science, Engineering and Mathematics (2010); and (5) NCI Cancer Prevention Fellowship Program Distinguished Alumni (2017-8).



    Christine Conageski, MD

    Christine Conageski, MD is currently an Assistant Professor of Obstetrics and Gynecology at the University of Colorado.  She graduated with a B.S. in Chemistry from Case Western Reserve University and earned her medical degree from the University Of Cincinnati School Of Medicine. Dr. Conageski has clinical interests in disorders of the lower genital tract and is the director of the vulvar specialty clinic at the University of Colorado.  She works with both medical students and residents as the Co-Clerkship Director of the Women's Health Block and Assistant Residency Director of Gynecology.




    Levi Downs, MD, MS

    Levi S. Downs, Jr, MD, MS, is Professor of Gynecologic Oncology in the Department of Obstetrics, Gynecology and Women’s Health at the University of Minnesota Medical School. Dr. Downs received his medical degree from the University of Pittsburgh School of Medicine in Pittsburgh, Pennsylvania. He did his residency in obstetrics and gynecology at Magee-Women’s Hospital at the University of Pittsburgh Medical Center.  Dr. Downs completed a fellowship in gynecologic oncology at the University of Minnesota and has a Master of Science degree in clinical research from the University Of Minnesota School of Public Health. Dr. Downs is the Chief Medical Officer of University of Minnesota Physicians and University of Minnesota Health where he partners with team members to coordinate physician lead clinical quality improvement initiatives and physician leadership of clinical operations. Dr. Downs has served as principal investigator for numerous clinical trials investigating ovarian and cervical cancers, chemotherapy, and therapeutic and preventive approaches to HPV related diseases. Among his many awards, Dr. Downs was recipient of the Robert Wood Johnson Foundation's Harold Amos Faculty Development Award. Among other societies Dr. Downs is also a member of the Society of Gynecologic Oncologists and serves on the Board of Directors of the American Society for Colposcopy and Cervical Pathology.



    Amber D'Souza, PhD, MS, MPH

    Amber D’Souza is an Associate Professor Epidemiology at the Johns Hopkins Bloomberg School of Public Health, with a joint appointment in the department of International Health and Otolaryngology-Head and Neck Surgery at the Johns Hopkins Sydney Kimmel Comprehensive Cancer center. She has a M.S. in Molecular and cellular biology from the University of Wisconsin-Madison (1999), an MPH in Disease Control (2001) from the University of Texas-Houston, and a PhD in infectious disease epidemiology from Johns Hopkins (2007). Dr. D’Souza leads a research program on infectious causes of cancer, global cancer, screening and prevention of cancer, and risk reduction among high risk populations. She is a member of the NIH National Cancer Institute HPV Vaccine Trial Working Group, and the American Dental Association Council on Scientific Affairs’ Cancer & Debilitating Diseases Subcommittee. She is multi-PI of the datacenter for the Multicenter AIDS Cohort Study (MACS), the longest observational epidemiologic study of HIV in the United States. Dr. D’Souza is a recognized expert on oral HPV infection and its role in head and neck cancer. She has over 100 publications and her research has been cited over 7,000 times (per Research Gate). She teaches one of the core epidemiologic methods courses at Johns Hopkins School of Public Health.



    Mark Einstein, MD, MS 

    Mark H. Einstein, MD, MS, FACS, FACOG, is Professor and Chair of the Department of Obstetrics, Gynecology and Women’s Health, and Assistant Dean of the Clinical Research Unit at Rutgers New Jersey Medical School.







    Michael Fitzsimmons, MD

    Michael Fitzsimmons, MD is a clinical instructor who practices orthopedic hand surgery at St. Joseph Mercy Hospital in Ypsilanti, Michigan.  He completed his residency in Orthopedic Surgery in 1990 at the University of Michigan.  He completed his hand surgery fellowship at Tampa General Hospital in 1991.  He has a particular interest in skin grafts and flaps.







    Lisa Flowers, MD

    Lisa Flowers, MD, is Professor in the Department of Gynecology & Obstetrics at Emory University School of Medicine. Dr. Flowers joined the Emory faculty in 1999. She is active on many national and state committees aimed at improving the quality and delivery of care and service to patients with cervical and breast disease, including work with the American Society for Colposcopy and Cervical Pathology, American College of Obstetrics and Gynecology, and American Cancer Society. Dr. Flowers is a member of Alpha Omega Alpha Honor Society, the American College of Obstetricians and Gynecologists, International Anal Neoplasia Society and is a member and on the Board of Directors of American Society for Colposcopy and Cervical Pathology. She is also on the DHHS/CDC Breast and Cervical Cancer Early Detection and Control Advisory Committee. Dr. Lisa Flowers received her medical degree from Case Western Reserve University School of Medicine, in Cleveland, Ohio. She completed her residency in obstetrics and gynecology at Magee-Women’s Hospital of the University of Pittsburgh Medical Center in 1996. Dr. Flowers is board certified in obstetrics and gynecology. Dr. Flowers’ research interests include treatment for HPV-related disease, HPV and cervical cancer educational programs, and ovarian cancer surveillance for women with breast cancer susceptibility genes. She is currently the Emory Principal Investigator for several clinical trials entailing biomarker discovery, risk assessment and treatment for anal neoplasia.



    Francisco Garcia, MD, MPH

    Dr. Francisco García is the Director and Chief Medical Officer of the Pima County Health Department in Tucson, Arizona. Dr. García is a member of the U.S. Preventive Services Task Force which produces national evidence-based clinical guidelines, as well as the Institute of Medicine Roundtable on Health Equity and the Elimination of Health Disparities.  Prior to joining Pima County Department of Health, he was a Distinguished Outreach Professor of Public Health and Obstetrics & Gynecology, and served in a variety of leadership roles at the University of Arizona including director of the Center of Excellence in Women’s Health, and the Cancer Disparities Institute of the Arizona Cancer Center. 




    Michael Gold, MD

    Dr. Gold is a Clinical Associate Professor in the Department of Obstetrics and Gynecology at the University of Oklahoma School of Community Medicine. Dr. Gold specializes in gynecologic oncology and pelvic surgery. Dr. Gold received his medical degree from Jefferson Medical College in Philadelphia, PA. He completed his residency in gynecology and obstetrics at Thomas Jefferson University Hospital, also in Philadelphia. After residency, Dr. Gold completed his three-year fellowship in gynecologic oncology at the University of Oklahoma Health Sciences Center in Oklahoma City, where he remained on the faculty for nine years. He then moved to Vanderbilt University Medical Center, where he was the Director of the Division of Gynecologic Oncology. Dr. Gold’s clinical interests include the prevention and treatment of cervical cancer and pre-cancer (dysplasia) of the cervix, vagina, and vulva. He is active in clinical research focusing on gynecologic cancers in general and the imaging of cervical and uterine cancer, in particular. Dr. Gold is board certified by the American Board of Obstetrics and Gynecology, Division of Gynecologic Oncology. Dr. Gold is a Fellow of the American College of Obstetricians and Gynecologists and the American College of Surgeons. He is an active member of the Gynecologic Oncology Group, the Society of Gynecologic Oncologists, the American Society of Colposcopy and Cervical Pathology, and the American College of Radiology Imaging Network.



    Richard Guido, MD

    Dr. Richard Guido is an obstetrician-gynecologist in Pittsburgh, Pennsylvania and is affiliated with multiple hospitals in the area, including Magee-Womens Hospital of UPMC and UPMC Passavant. He received his medical degree from University of Rochester School of Medicine and Dentistry and has been in practice for 28 years. He is one of 164 doctors at Magee-Womens Hospital of UPMC and one of 57 at UPMC Passavant who specialize in Obstetrics & Gynecology. Dr. Guido is the Chairman of the University of Pittsburgh IRB, and is Past President of ASCCP.





    Hope Haefner, MD

    Hope K. Haefner, M.D. is a professor in the Department of Obstetrics and Gynecology at Michigan Medicine. She opened the University of Michigan Center for Vulvar Diseases in 1993. She is a past president of the American Society for Colposcopy and Cervical Pathology. She is a past president of the International Society for the Study of Vulvovaginal Disease. Her particular research interests are in vulvodynia and non-neoplastic epithelial disorders of the vulva. Dr. Haefner has a special interest in education. She was Residency Director at the University of Michigan Department of Obstetrics and Gynecology from 1999 to 2003. Currently, she is involved internationally with vulvovaginal disease education.





    Warner Huh, MD

    Warner K. Huh, MD is Professor and Division Director in the Division of Gynecologic Oncology and the Margaret Cameron Spain Endowed Chair in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB) and a Senior Scientist in the UAB Comprehensive Cancer Center. His research interests revolve around screening and prevention of HPV related diseases as well as novel immunotherapeutic approaches for pre-invasive disease of the cervix as well as cervical cancer. He has authored or co-authored over 200 articles including numerous publications in the area of prophylactic HPV vaccination including the New England Journal of Medicine, Journal of the National Cancer Institute, Lancet Oncology, Cancer, Clinical Cancer Research, Gynecologic Oncology, Obstetrics & Gynecology, and the American Journal of Obstetrics & Gynecology.





    Sandy James, JD, MA

    Sandy James is the Research Director at the National Center for Transgender Equality and the lead author of The Report of the 2015 U.S. Transgender Survey. In that role, he led a research team in the development, fielding, analysis, and presentation of the 2015 U.S. Transgender Survey. After spending a decade as a forensic toxicologist, Sandy launched a new career as a civil rights advocate focused on laws and policies that affect trans people. He has worked on numerous projects involving trans-related legislation, policy, and research, including extensive work with data from the 2008–09 National Transgender Discrimination Survey. Sandy has been published in The Georgetown Journal of Gender and the Law and the LGBTQ Policy Journal at the Harvard Kennedy School. Sandy received a J.D and M.A in American Government from Georgetown University, where he is also currently pursuing his Ph.D.




    Naomi Jay, PhD, NP

    Naomi Jay is an assistant clinical professor of nursing at the UCSF School of Nursing. Since 1991 she has worked in the UCSF Division of Medicine specializing in the detection and diagnosis of HPV-associated anal canal disease. She pioneered the use of colposcopic methodology for high-resolution anoscopy and is recognized internationally for her expertise in the field. Dr. Jay was a founding member of the International Anal Neoplasia Society and currently serves as the president. She also serves on the board of the ASCCP.





    Jose Jeronimo, MD

    Dr. Jeronimo is a gynecologist oncologist; he started his career in Peru. Later he was staff scientist for the Division of Cancer Epidemiology and Genetics at the National Cancer Institute (NCI/NIH). In 2008 he joined PATH (Seattle) to lead the validation and demonstration of new molecular technologies for cervical cancer screening. Currently he is the Chief Technical Officer at the Global Coalition against Cervical Cancer (GC3). Dr. Jeronimo is a member of the board of directors of the International Papilloma Virus Society; board of directors of ASCCP; editor of the Papilloma Virus Research Journal; member of the editorial board of the journal of the ASCCP, and advisor for the cervical cancer screening Lab to Scale Program at Duke University. He chaired the group that developed the ASCO resource-stratified guidelines for cervical cancer prevention. He received multiple honors during his career, including the Distinguished Scientific Award from ASCCP.



    Hormuzd Katki, PhD

    Hormuzd A. Katki received a B.S. in math from the University of Chicago and an M.S. in statistics from Carnegie-Mellon University. He received a Ph.D in biostatistics from Johns Hopkins University in 2006, where he received the Margaret Merrell Award for research by a biostatistics doctoral student. Dr. Katki joined the National Cancer Institute 1999, became a principal investigator in 2009, and was appointed senior investigator upon receiving National Institute of Health scientific tenure in 2015. Dr. Katki’s research focuses on understanding how epidemiologic findings could be used to prevent cancer in individuals and in populations. In particular, he develops and applies quantitative methods to both identify and answer the most pressing epidemiologic questions for advancing cancer prevention. He is particularly interested in developing risk-based approaches to cancer screening.




    Christina Mangurian, MD, MAS

    Dr. Mangurian is an Associate Professor of Psychiatry at UCSF School of Medicine and the UCSF Department of Psychiatry's Vice Chair for Diversity. Dr. Mangurian is an NIH funded scientist who directs the UCSF Program of Research on Mental health Integration among Underserved and Minority populations (PReMIUM) which is based at the UCSF Center for Vulnerable Populations (http://integration.ucsf.edu/).






    Constance Mao, MD

    Dr. Mao is an Associate Professor in the Department of Obstetrics and Gynecology at the University of Washington School of Medicine in Seattle, Washington.







    Lynette Margesson, MD

    Dr. Margesson is Adjunct Assistant Professor of Obstetrics and Gynecology and Surgery (Dermatology) at Geisel School of Medicine at Dartmouth.  She holds vulvar clinics at the Dartmouth Hitchcock Medical Center monthly in the Department of Obstetrics and Gynecology. She is very active in vulvar teaching, lecturing locally, nationally and internationally, is active in the International Society for the Study of Vulvovaginal Disease (ISSVD) and teaches regularly at the American Academy of Dermatology and the American College of Obstetrics and Gynecology meetings.  She is the author of two textbooks on vulvar disease and has been a contributor to several others. She received her medical degree from University of Western Ontario in 1970 and finished her Fellowship in Dermatology in 1975 in Toronto.  She was on the teaching staff at Queens University from 1976 until 1997 where she started the first combined vulvar teaching clinic in Canada with the Department of Obstetrics and Gynecology.  She moved to New Hampshire in 1997 and has a clinic in Manchester. She is now living in Maine. She is committed to promoting vulvar education and awareness of vulvar conditions.



    L. Stewart Massad, MD

    Dr. Massad is a professor in the Division of Gynecologic Oncology at Washington University in St. Louis and gynecologic for the St. Louis VA Medical Center. He was the lead coordinator of the 2012 ASCCP Guidelines for Management of Abnormal Cervical Cancer Screening Tests and CIN/AIS. He was a member of the steering committee that developed the 2017 ASCCP Colposcopy Standards. His research focus has been on the intersection of HPV and HIV infection.






    E.J. Mayeaux, MD

    E.J. Mayeaux, Jr., MD, (Professor and Chair, Department of Family and Preventive Medicine at the University of South Carolina (USC) School of Medicine). Prior to joining USC, Dr. Mayeaux worked for over 23 years at Louisiana State University Medical Center in Shreveport and as a Professor of Family Medicine and of Ob/Gyn. Dr. Mayeaux is a well-respected educator. He has published and edited 8 books including the Color Atlas of Family Medicine and the Essential Guide to Primary Care Procedures. He is a Diplomate of the American Board of Family Practice, a Fellow of the American Academy of Family Physicians and a diplomate of the American board of Preventive Medicine. He is currently on the executive board of ASCCP and was President in 2014. He was the lead editor of the ASCCP’s Modern Colposcopy. He also serves on the executive board of the International Federation for Colposcopy and Pathology of the Cervix. Dr. Mayeaux’s clinical expertise includes women’s health topics such as cervical disease, HPV disease, HPV vaccination, skin diseases and patient literacy. He has a passion for women’s health and teaching, and is a frequent U.S. National and international invited speaker.



    Anna-Barbara Moscicki, MD

    Dr. Anna-Barbara Moscicki is Professor of Pediatrics at UCLA, Division Chief of Adolescent and Young Adult Medicine, and Associate Vice Chair of Clinical Research, Department of Pediatric. Dr. Moscicki is president of the ASCCP. Dr. Moscicki’s career has focused on adolescent gynecology and sexually transmitted infection research with a specific focus in Human Papillomavirus, HIV infection and mucosal immunology. Dr. Moscicki has been the principle investigator of a natural history study of HPV in adolescents and young women since 1990, one of the longest running HPV cohorts. Her work was highly influential in forming the new cervical cancer screening guidelines and triage of abnormal cytology in young women. Her recent work focuses on mucosal immunology and the vaginal microbiota. She has been involved in numerous clinical trials including vaginal microbiocides and an ongoing one-dose HPV vaccine trial.  She is also involved in health outcomes in perinatally HIV infected children including HPV vaccine efficacy, sexual risk behaviors, substance use, oral health, microbiomes, and HPV infections and has worked with numerous Networks on HIV disease in children and adolescents including Adolescent Medicine HIV/AIDS Research Network, Adolescent Therapeutic Network, IMPAACT and PHACS.  She has over 150 publications and she serves on numerous national and international committees, including the W.H.O., N.I.H., ASCCP, and the American Cancer Society.



    Juno Obedin-Maliver, MD, MPH, MAS

    Dr. Obedin-Maliver is an Assistant Professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at the University of California, San Francisco. She is the Chief of Gynecology at the San Francisco Veterans Affairs Medical Center. Academically she focuses on promoting the health of and well-being sexual and gender minorities which include but are not limited to lesbian, gay, bisexual, and transgender, and queer (LGBTQ) people. Dr. Obedin-Maliver, is the Co-Director of The PRIDE Study (pridestudy.org), an online prospective longitudinal cohort of sexual and gender minority individuals based at University of California, San Francisco (UCSF).





    Rajal Patel, MD

    Rajal Patel, MD is a clinical lecturer in the department of Obstetrics and Gynecology at Michigan Medicine. She completed her medical training at Northwestern University in Chicago, IL and residency at the University of Wisconsin in Madison, WI. Dr. Patel has a special interest in vulvar diseases and is pursuing advanced training in the field at the Center for Vulvar Diseases at the University of Michigan.




    Mona Saraiya, MD, MPH

    Mona Saraiya, MD, MPH, leads the global cancer portfolio at CDC since 2010. She has been serving in the role as Associate Director in the Division of Cancer Prevention and Control’s (DCPC’s) Office of International Cancer Control since 2014. Prior to her current position, Dr. Saraiya served as a medical officer and worked on domestic issues related to skin cancer epidemiology and cervical cancer prevention and control. Her cervical cancer and HPV research portfolio includes an initiative to characterize the HPV-associated cancer burden in the United States, and adherence to cervical cancer screening guidelines, especially with newer technologies such as HPV testing. She graduated from Rush Medical College, completed a Masters of Public Health at Emory School of Public Health and completed a residency in Preventive Medicine/Public Health and is board certified by the American College of Preventive Medicine. Dr, Saraiya is an alumnus of the EIS program and is an adjunct professor at Emory University and at Morehouse School of Medicine and has published over 150 articles during her tenure at CDC.




    Mark Schiffman, MD, MPH

    National Cancer Institute
    Division of Cancer Epidemiology & Genetics, Clinical Genetics Branch





    Peter Schnatz, DO

    Dr. Schnatz is the Associate Chairman and Residency Program Director in the Department of ObGyn at The Reading Hospital in Pennsylvania. He is Professor of ObGyn and of Internal Medicine at the Sidney Kimmel Medical College at Thomas Jefferson University in Philadelphia. Dr. Schnatz has served on the American Society of Colposcopy and Cervical Pathology’s (ASCCP) AD-HOC Committee on Research, and is the Co-Chair of ASCCP’s Education Committee. He also serves as a member of the Editorial Board of the Journal of Lower Genital Tract Disease - The journal of the ASCCP. Dr. Schnatz is the Immediate Past President of the North American Menopause Society (NAMS), is on the Editorial Board of the Journal Menopause, is a past Chair of the NAMS Professional Education Committee, is a member of the NAMS Executive Committee, is the President Elect of The Obstetrical Society of Philadelphia, is the CREOG Region II Program Director’s Representative to the CREOG Council, and is a reviewer for multiple journals. Dr. Schnatz is also the Chairman of the Board and CEO of FaithCare, Incorporated, an organization involved in humanitarian aid both locally and internationally. Dr. Schnatz is a NAMS Certified Menopause Practitioner and is actively involved as both a clinician and a researcher. Dr. Schnatz’s research interests include menopause (hormonal therapy, vitamin D, and coronary artery disease), cervical dysplasia, Atypical Glandular Cells, and medical education. Dr. Schnatz has given numerous Regional, National, and International lectures. Dr. Schnatz has over 175 publications, close to 100 abstract presentations, more than a dozen award winning papers and/or presentations. Dr. Schnatz graduated from the Rowan University School of Osteopathic Medicine and completed his Internal Medicine and ObGyn residencies at The University of Connecticut (UConn), in Farmington, Connecticut.



    Elizabeth Stier, MD

    Elizabeth Stier is an associate professor of Obstetrics and Gynecology at Boston University School of Medicine and vice chair of the HPV working group of the NCI sponsored AIDS Malignancy Consortium. She is a clinical researcher with a particular interest in the prevention of anogenital HPV-associated cancers in HIV-positive men and women.





    Colleen Stockdale, MD, MS

    Colleen Kennedy Stockdale MD, MS is a Clinical Associate Professor of Obstetrics and Gynecology at the University of Iowa.  She is the Director of the Colposcopy and Vulvar Vaginal Disease Clinics, as well as the Obstetrics and Gynecology Clerkship Director. Dr. Stockdale has served as an ASCCP Board Member since 2010 and has served as faculty for several postgraduate courses and clinical meetings in addition to her service on committees.






    Howard Strickler, MD, MPH

    Albert Einstein College of Medicine
    Co-Leader, Cancer Epidemiology Program, Albert Einstein Cancer Center
    Division Head, Division of Epidemiology & Population Health
    Harold and Muriel Block Chair in Epidemiology




    Vin Tangpricha, MD, PhD

    Vin Tangpricha is an Associate Professor of Medicine in the Division of Endocrinology, Metabolism and Lipids at Emory University School of Medicine, USA. Dr. Tangpricha received his medical degree from Tufts University School of Medicine, USA. He completed his internal medicine residency and endocrinology fellowship at Boston University Medical Center, USA. He completed his Ph.D. degree in molecular medicine on the topic of vitamin D at Boston University School of Medicine. He currently serves as the Program Director for the endocrinology fellowship training program and the American Board of Internal Medicine Physician Scientist Research Track internal medicine residency program at Emory. He serves on the Endocrine Society guidelines committee for the hormone treatment of transgender patients and is a member of the American Association of Clinical Endocrinologists and World Professional Association for Transgender health (WPATH) board of directors. He is co-author of the WPATH Standards of Care for transgender persons. He has received a number of awards including the first Emory Transgender Advocate Award in 2011 and the American Association for Clinical Endocrinologists 2016 Outstanding Service for an Underserved Community for his work with the transgender community.




    Candice Tedeschi, NP

    Candice Tedeschi, Women's Health Nurse Practitioner, works as a Nurse Practitioner in private practice on Long Island, New York specializing in diagnosis and management of women with lower genital tract disease. Candy currently serves on ASCCP’s Assessment Committee and the Colposcopy Standards Committee. Candy has been involved with Indian Health Services educational programs since the mid-1990s. She has served on the Board of Directors for ASCCP and DES Action, a national consumer organization, and has participated in NIH and CDC studies for the DES exposed in utero population.




    Alan Waxman, MD, MPH

     Dr. Waxman is a Professor of Obstetrics and Gynecology at the University of New Mexico School of Medicine in Albuquerque where he directs the Colposcopy and LEEP clinics. He joined the faculty of UNM in 2000 after completing a 24 year career in the U.S. Public Health Service working in the Indian Health Service (IHS) in Gallup New Mexico and Anchorage Alaska. He served 6 years as Chief Clinical Consultant for Obstetrics and Gynecology of the Indian Health Service. Dr. Waxman’s principle area of interest since 1991 has been cervical cancer screening and prevention. He served on the board of directors of the American Society for Colposcopy and Cervical Pathology (ASCCP) from 1996 to 2006 and again from 2010-2016.  He served as co-chair of numerous committees and was the Society’s President 2012-2013.  He helped establish the Society’s curriculum for colposcopy education and helped develop its Colposcopy Mentorship Program for advanced practice nurses and physicians. He has lectured nationally and internationally on cervical cancer prevention, human papillomavirus and colposcopy. He is a past co-Chair of ASCCP’s Committee on International Education and Humanitarian Outreach.  In that capacity directed colposcopy education programs in numerous low and middle resource countries with high rates of cervical cancer. He has been course director and/or on the faculty of postgraduate courses on colposcopy and cervical cancer screening produced by the American College of Obstetricians and Gynecologists (ACOG) and ASCCP.  He is the former co-director of ASCCP’s Comprehensive Colposcopy Courses and director of the U.S. Indian Health Service’s Colposcopy Training Program. He has served on national and regional medical advisory boards of the National Breast and Cervical Cancer Early Detection Program. He has authored numerous articles and book chapters on colposcopy, cervical cancer screening, colposcopy education, and related subjects.


    Li-Hui Wei, MD

    Prof. Wei has been working as a gynecologist and oncologist for many years, mainly engaged in the clinical and scientific research of gynecological malignant tumors, as well as research on the pathogenesis and the treatment of endometrial cancer. In addition, she has conducted a series of research on cervical cancer screening as well as treatment. As the PI of HPV vaccine (Gardasil), she has undertaken the phase III clinical trial in China and has also been involved in the phase III clinical trial of China-made HPV vaccine. In 2015, the Chinese Society for Colposcopy and Cervical Pathology (CSCCP) was established by Dr. Wei as the president, further promoting the cervical cancer prevention in China. Dr. Wei is also Vice-President, China Medical Women’s Association (CMWA), Vice-President, Chinese Obstetricians and Gynecologists Association (COGA), Professor, Dep. Obstetrics and Gynecology, Peking University People’s Hospital, Honorary Director, Dep. Obstetrics and Gynecology, Peking University, Editor-in-Chief, Chinese Journal of Clinical Obstetrics and Gynecology, and Deputy Editor-in-Chief, Chinese Journal of Obstetrics and Gynecology.




    Nicolas Wentzensen, MD, PhD, MS

    Dr. Wentzensen is a Senior Investigator and head of the Clinical Epidemiology Unit at the Division of Cancer Epidemiology and Genetics, National Cancer Institute. He earned his MD and a PhD in Applied Tumor Biology from the University of Heidelberg and a Master of Epidemiology from the University of Mainz before joining the National Cancer Institute in 2007. Dr. Wentzensen is conducting molecular epidemiology studies to understand the etiology of gynecological cancers and to develop new prevention methods. Dr. Wentzensen has worked on HPV-associated cancers for 20 years and has focused on cervical disease detection and the development of biomarkers for cervical cancer screening from basic research to translation in clinical and epidemiological studies. He is leading studies to clinically validate novel biomarkers for triage of HPV-positive women and he has established studies to analyze the accuracy of cervical colposcopy and biopsy in women with abnormal screening results. Furthermore, he is the lead investigator of a large cervical cancer biomarker research and discovery effort conducted at NCI. Dr. Wentzensen has served and is serving as an expert on several national and international committees, including the ACS, ASCCP, and ASCP Screening Guidelines for the Prevention and Early Detection of Cervical Cancer, the ASCCP Management Guidelines, and the ASCCP Colposcopy Standards Effort.



    Yun Zhao, MD, PhD

    Peking University People's Hospital
    Beijing, China